Tango Therapeutics (TNGX) Superinvestor holders
12 of the superinvestors we track hold Tango Therapeutics (TNGX) in their latest 13F filings, $553M in total.
Summary
The largest holder is Tom Steyer (Farallon Capital Management LLC), with $384M, 2.3% of the portfolio.
In their latest quarter: 3 opened a new position, 4 added, 5 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Tom Steyer Farallon Capital Management LLC |
Added | 12,277,000 | $384M | 2.3% | Q2 2026 |
| Brandon Haley Holocene Advisors |
Trimmed | 2,410,939 | $75M | 0.2% | Q2 2026 |
| Ken Fisher Fisher Investments |
Added | 1,068,505 | $27M | 0.0% | Q3 2026 |
| Jim Simons Renaissance Technologies |
New position | 748,300 | $23M | 0.0% | Q2 2026 |
| Wilmot Harkey Nantahala Capital Management |
Trimmed | 500,659 | $16M | 0.9% | Q2 2026 |
| Steve Cohen Point72 Asset Management |
Trimmed | 298,339 | $9M | 0.0% | Q2 2026 |
| Two Sigma Two Sigma Investments |
Added | 241,783 | $8M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
New position | 174,909 | $5M | 0.0% | Q2 2026 |
| Cliff Asness AQR Capital Management |
Trimmed | 91,029 | $3M | 0.0% | Q2 2026 |
| Alger Fred Alger Management |
Trimmed | 69,038 | $2M | 0.0% | Q2 2026 |
| Ron Baron Baron Capital (BAMCO) |
New position | 15,000 | $468,900 | 0.0% | Q2 2026 |
| Acadian Acadian Asset Management |
Added | 7,382 | $184,000 | 0.0% | Q3 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 12 |
| Q1 2026 | 9 |
| Q4 2025 | 11 |
| Q3 2025 | 12 |
| Q2 2025 | 9 |
| Q1 2025 | 11 |
| Q4 2024 | 11 |
| Q3 2024 | 8 |
Questions about Tango Therapeutics
Which superinvestors own Tango Therapeutics?
12 of the superinvestors we track hold Tango Therapeutics (TNGX) in their latest 13F filings, $553M in total. Tom Steyer, Brandon Haley, Ken Fisher, Jim Simons, Wilmot Harkey, Steve Cohen.
Who is the largest superinvestor holder of TNGX?
The largest holder is Tom Steyer (Farallon Capital Management LLC), with $384M, 2.3% of the portfolio.
From Tango Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.